Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, GOSH, London, UK.
Centre for Rheumatology Research, Division of Medicine, UCL, London, UK.
Nat Commun. 2020 Dec 9;11(1):6317. doi: 10.1038/s41467-020-19741-6.
Anecdotal evidence suggests that Coronavirus disease 2019 (COVID-19), caused by the coronavirus SARS-CoV-2, exhibits differences in morbidity and mortality between sexes. Here, we present a meta-analysis of 3,111,714 reported global cases to demonstrate that, whilst there is no difference in the proportion of males and females with confirmed COVID-19, male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission (OR = 2.84; 95% CI = 2.06, 3.92) and higher odds of death (OR = 1.39; 95% CI = 1.31, 1.47) compared to females. With few exceptions, the sex bias observed in COVID-19 is a worldwide phenomenon. An appreciation of how sex is influencing COVID-19 outcomes will have important implications for clinical management and mitigation strategies for this disease.
有传闻证据表明,由冠状病毒 SARS-CoV-2 引起的 2019 年冠状病毒病 (COVID-19) 在发病率和死亡率方面存在性别差异。在这里,我们对全球报告的 3111714 例确诊病例进行了荟萃分析,以证明尽管 COVID-19 中男性和女性的确诊比例没有差异,但男性患者接受重症监护病房 (ITU) 入院治疗的可能性几乎是女性的三倍(OR=2.84;95%CI=2.06,3.92),且死亡的可能性更高(OR=1.39;95%CI=1.31,1.47)。除了少数例外,在 COVID-19 中观察到的性别偏见是一种全球现象。了解性别如何影响 COVID-19 的结果,对于该疾病的临床管理和缓解策略具有重要意义。